Trends and Risk Factors for 1-Year Revision of the Latarjet Procedure: The New York State Experience During the Past Decade

Orthopedics. 2018 May 1;41(3):e389-e394. doi: 10.3928/01477447-20180320-07. Epub 2018 Mar 26.

Abstract

Little research has been conducted evaluating surgical trends during the past 10 years and subsequent procedure risk factors for patients undergoing bone-blocking procedures for the treatment of anterior shoulder instability. The Statewide Planning and Research Cooperative System database was queried between 2003 and 2014 to identify patients undergoing soft tissue or bone-blocking procedures for anterior shoulder instability in New York. Patient demographics and 1-year subsequent procedures were analyzed. Multivariate logistic regression analyses were conducted to identify 1-year subsequent procedure risk factors. From 2003 through 2014, a total of 540 patients had Latarjet procedures performed. During this period, the volume of Latarjet procedures increased by 950%, from 12 procedures in 2003 to 126 procedures in 2014. The volume of open Bankart repairs declined by 77%; arthroscopic Bankart repairs fluctuated, being up (328%) between 2003 and 2012 and then down (6%) between 2012 and 2014. Of the 540 patients, 2.4% (13 of 540) required intervention for recurrent shoulder instability events. Age older than 20 years and workers' compensation were identified as independent risk factors for reoperation. The number of bone-blocking procedures, such as the Latarjet, has increased by nearly 1000% during the past decade in New York. Only 2.4% (13 of 540) of the patients had subsequent shoulder instability interventions. [Orthopedics. 2018; 41(3):e389-e394.].

MeSH terms

  • Adult
  • Female
  • Humans
  • Joint Instability / surgery*
  • Logistic Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • New York
  • Orthopedic Procedures / methods
  • Orthopedic Procedures / trends*
  • Recurrence
  • Reoperation / trends*
  • Retrospective Studies
  • Risk Factors
  • Shoulder Joint / surgery*
  • Treatment Outcome